MarketPeel
Insider Trading Intelligence
JC

Joseph H. Capper

ANIK
DIRECTOR · ANIKA THERAPEUTICS, INC. · CIK 0001456817
FILING MIX · LIFETIME53%/47%
BUYS
20
SELLS
18
TOTAL VALUE
$85.99M
COMPANIES
5
ACTIVE SINCE
Feb 2020
HOLDINGS NOW
4,179,440
AVG SELL PX
$64.26
TRADE KIND
SHOWING 38 / 38
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
3 backtested trades · 8 horizons · 1 pending
Forward-return performance of every backtestable P/S trade by Joseph H. Capper, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d3+100.00%+5.15%+0.76%+4.39%+1.05%
14d3+100.00%+5.26%+2.27%+2.99%+1.79%
30d3+100.00%+12.03%+4.34%+7.69%+10.81%
60d3+66.67%+9.67%+3.59%+6.08%+13.43%
90d3+100.00%+18.43%+4.10%+14.33%+19.45%
180d3+100.00%+32.00%+13.27%+18.74%+29.85%
1y3+66.67%-9.14%+27.03%-36.17%-20.94%
2y3(1 pending)+0.00%-8.35%+40.58%-48.93%-48.93%
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
ANIK · 30,805 shares · as of Jun 18, 2026
07,70115,40323,10430,80520252026SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2020
2020
2020
2020
2021
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
FLOW · 20 buys / 18 sellsCOVERAGE · 26 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
ANIK
ANIKA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
10,40230,805Jun 18, 2026Jun 23, 2026View →
TELA
TELA BIO, INC.
PURCHASEGRANT
Stock grant
17,55017,550Jun 9, 2026Jun 11, 2026View →
TELA
TELA BIO, INC.
PURCHASEGRANT
Stock grant
17,33517,335Jun 9, 2026Jun 11, 2026View →
TELA
TELA BIO, INC.
PURCHASEGRANT
Stock grant
11,92511,925Jun 9, 2026Jun 11, 2026View →
TELA
TELA BIO, INC.
PURCHASEGRANT
Stock grant
11,67523,600Jun 9, 2026Jun 11, 2026View →
MDXG
MIMEDX GROUP, INC.
PURCHASEGRANT
Stock grant
371,094904,656Mar 4, 2026Mar 6, 2026View →
MDXG
MIMEDX GROUP, INC.
PURCHASEGRANT
Stock grant
310,5744,087,938Mar 4, 2026Mar 6, 2026View →
ANIK
ANIKA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
14,16420,403Jun 20, 2025Jun 24, 2025View →
MDXG
MIMEDX GROUP, INC.
PURCHASE
Chief Executive Officer
200,000$6.34$1.27M529,530May 2, 2025May 5, 2025View →
MDXG
MIMEDX GROUP, INC.
PURCHASEGRANT
Stock grant
177,3643,777,364Mar 3, 2025Mar 5, 2025View →
MDXG
MIMEDX GROUP, INC.
PURCHASEGRANT
Stock grant
223,268329,530Mar 3, 2025Mar 5, 2025View →
ANIK
ANIKA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
5,7716,239Jul 9, 2024Jul 11, 2024View →
ANIK
ANIKA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
468468Jun 3, 2024Jun 5, 2024View →
MDXG
MIMEDX GROUP, INC.
PURCHASE
Chief Executive Officer
42,025$6.50$273.3K100,000Jun 23, 2023Jun 26, 2023View →
MDXG
MIMEDX GROUP, INC.
PURCHASE
Chief Executive Officer
57,975$6.33$367.1K57,975Jun 22, 2023Jun 26, 2023View →
STIM
NEURONETICS, INC.
PURCHASEGRANT
Stock grant
36,36443,147May 25, 2023May 30, 2023View →
MDXG
MIMEDX GROUP, INC.
PURCHASEGRANT
Stock grant
3,600,0003,600,000Jan 27, 2023Jan 31, 2023View →
STIM
NEURONETICS, INC.
PURCHASEGRANT
Stock grant
5,7836,783Jan 1, 2023Jan 4, 2023View →
BEAT
HEARTBEAM, INC.
SALE
President & CEO
122,538$61.64$7.55M0Feb 9, 2021Feb 11, 2021View →
BEAT
HEARTBEAM, INC.
SALE
President & CEO
42,291$18.78$794.2K0Feb 9, 2021Feb 11, 2021View →
BEAT
HEARTBEAM, INC.
SALE
President & CEO
49,604$38.65$1.92M0Feb 9, 2021Feb 11, 2021View →
BEAT
HEARTBEAM, INC.
SALE
President & CEO
104,468$63.32$6.61M0Feb 9, 2021Feb 11, 2021View →
BEAT
HEARTBEAM, INC.
SALE
President & CEO
17,762$72.00$1.28M0Feb 9, 2021Feb 11, 2021View →
BEAT
HEARTBEAM, INC.
SALE
President & CEO
313,232$69.20$21.68M0Feb 9, 2021Feb 11, 2021View →
BEAT
HEARTBEAM, INC.
SALE
President & CEO
94,752$62.43$5.92M0Feb 9, 2021Feb 11, 2021View →
BEAT
HEARTBEAM, INC.
SALE
President & CEO
20,834$72.00$1.50M0Feb 9, 2021Feb 11, 2021View →
BEAT
HEARTBEAM, INC.
SALE
President & CEO
162,772$72.00$11.72M0Feb 9, 2021Feb 11, 2021View →
BEAT
HEARTBEAM, INC.
SALE
President & CEO
54,235$67.33$3.65M0Feb 9, 2021Feb 11, 2021View →
BEAT
HEARTBEAM, INC.
SALE
President & CEO
257,177$69.46$17.86M0Feb 9, 2021Feb 11, 2021View →
BEAT
HEARTBEAM, INC.
SALE
President & CEO
45,917$47.35$2.17M0Feb 9, 2021Feb 11, 2021View →
BEAT
HEARTBEAM, INC.
SALE
President & CEO
10,946$72.00$788.1K0Feb 9, 2021Feb 11, 2021View →
BEAT
HEARTBEAM, INC.
SALEGRANT
Gift
1,400164,172Feb 3, 2021Feb 11, 2021View →
BEAT
HEARTBEAM, INC.
SALEGRANT
Gift
1,400162,772Feb 3, 2021Feb 11, 2021View →
BEAT
HEARTBEAM, INC.
SALEGRANT
Gift
1,400165,572Dec 29, 2020Feb 11, 2021View →
BEAT
HEARTBEAM, INC.
SALEGRANT
Gift
1,400166,972Dec 28, 2020Feb 11, 2021View →
BEAT
HEARTBEAM, INC.
PURCHASEGRANT
Stock grant
17,762168,372Feb 18, 2020Feb 20, 2020View →
BEAT
HEARTBEAM, INC.
PURCHASEGRANT
Stock grant
42,29142,291Feb 18, 2020Feb 20, 2020View →
BEAT
HEARTBEAM, INC.
SALE
President & CEO
11,831$53.52$633.2K150,611Feb 14, 2020Feb 19, 2020View →
Other insiders · ANIK
Loading peer insiders…
About this filer
CIK 0001456817
ROLE
Director
PRIMARY
ANIK
COMPANIES
5
ACTIVE SINCE
Feb 2020
MARKETPEEL · /INSIDER/0001456817DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback